Denemek ALTIN - Özgür
Role of global pharma industry in TB diagnostics - II
Chronicle Pharmabiz
|August 21, 2025
IN the first part of this article, the authors described the TB remains a persistent global health challenge, particularly in lowand middle-income countries, and the global pharma industry has been at the forefront of TB diagnostics. In this concluding part, they are discussing about traditional sample transportation methods, DBS and dried sputum technologies, advanced molecular transport media & impact on TB diagnostics and public health.
Traditional sample transportation methods
Historically, TB sample transportation has relied heavily on conventional methods, such as cold chain systems, where samples are kept refrigerated or frozen during transit. This method is effective in preserving the viability of samples, particularly for sputum and other biological materials that are prone to degradation at room temperature. However, maintaining a cold chain can be challenging, especially in remote or resource-limited areas where access to electricity and reliable refrigeration is limited.
Strengths
Preserves sample integrity: Cold chain systems are effective in maintaining the viability of TB samples, which is crucial for accurate diagnostic results.
Widely adopted: Cold chain logistics are well-established and commonly used across various medical and research fields, making them a standard practice in TB sample transportation.
Limitations
Logistical challenges: Maintaining a cold chain requires reliable infrastructure, including continuous power supply and proper storage facilities, which may not be available in remote areas.
High costs: The need for refrigeration, specialized packaging, and temperature monitoring increases the overall cost of transportation, making it less feasible for widespread use in low-income regions.
Limited reach: Cold chain-dependent solutions are less accessible in regions with poor infrastructure, limiting their effectiveness in those areas most affected by TB.
DBS and dried sputum technologies
To address the challenges of cold chain logistics, alternative methods such as Dried Blood Spot (DBS) and dried sputum technologies have been developed. These methods involve collecting samples on specially treated paper, which allows them to be dried and stored at room temperature for extended periods.
Bu hikaye Chronicle Pharmabiz dergisinin August 21, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Chronicle Pharmabiz'den DAHA FAZLA HİKAYE
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
